Preferential apical infection and spread of human metapneumovirus highlights the importance of inhaled delivery of neutralizing monoclonal antibody to treat established infections
Proceedings of the National Academy of Sciences · 30.09.2025 · 122 (39)
DOI: 10.1073/pnas.2502897122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 23.09.2025. Verfasst von Karthik Tiruthani und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, N…. Hauptthemen laut MEDLINE: Metapneumovirus, Paramyxoviridae Infections, Antibodies, Viral, Antibodies, Neutralizing. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: UNC | UNC-CH | UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill (UNC Eshelman School of Pharmacy), NIAID NIH HHS, HHS | NIH (NIH).
Abstract (Originalsprache)
Human metapneumovirus (hMPV) is a frequent cause of acute respiratory infections in infants, the elderly, and the immunocompromised. No vaccines or treatments are currently available beyond supportive care. Building on our previous work with parainfluenza viruses and respiratory syncytial virus, we investigate the pattern of hMPV infection and spread in polarized and well-differentiated cultures of human airway epithelium (WD-HAE). We found productive infection of WD-HAE requires apical inoculation of hMPV, with infectious spread dependent on progeny viruses shedding into mucus secretions overlaying the apical surface of WD-HAE. A potent neutralizing monoclonal antibodies (mAb) against hMPV fusion protein—mAb364 (also termed MPV364)—prevented initial infection by hMPV and halted spread of established hMPV infection when dosed directly to the apical surface of WD-HAE. Conversely, mAb364 delivered to the basal compartment was unable to curb established infections, even at 100-fold greater concentrations. Intranasal delivery of mAb364 to hamsters with established hMPV infections reduced viral titers by ~four logs within 2 d and alleviated key pathological outcomes of hMPV infection. These results are consistent with hMPV infection and continued spread occurring via the apical surface of the respiratory epithelium, and underscore delivery of neutralizing mAbs to the respiratory tract as an effective intervention against established hMPV infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.
- University of North Carolina at Chapel Hill Marsico Lung Institute, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.
- University of North Carolina at Chapel Hill/North Carolina State University Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.
- Department of Pharmacology and Toxicology, Michigan State University, East Lansing, MI 48824.
- Department of Biomedical Sciences, College of Medicine, Florida State University, Tallahassee, FL 32306.
- Department of Microbiology and Immunology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.
ORCID-Profile: Madison P Card, Jack R Harkema, Jarrod J Mousa, Samuel K Lai
Förderung
- UNC | UNC-CH | UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill (UNC Eshelman School of Pharmacy)
- NIAID NIH HHS
- HHS | NIH (NIH)
- NHLBI NIH HHS
- NIDDK NIH HHS
Zitieren
APA
Tiruthani, K., Card, M. P., Wolf, W., Shen, L., Schaefer, A., Fritz, M., Okuda, K., Harkema, J. R., Mousa, J. J., J Pickles, R., & Lai, S. K. (2025). Preferential apical infection and spread of human metapneumovirus highlights the importance of inhaled delivery of neutralizing monoclonal antibody to treat established infections. Proceedings of the National Academy of Sciences, 122(39). https://doi.org/10.1073/pnas.2502897122
Vancouver
Tiruthani K, Card MP, Wolf W, Shen L, Schaefer A, Fritz M, et al. Preferential apical infection and spread of human metapneumovirus highlights the importance of inhaled delivery of neutralizing monoclonal antibody to treat established infections. Proceedings of the National Academy of Sciences. 2025;122(39). doi:10.1073/pnas.2502897122
BibTeX
@article{Tiruthani2025,
author = {Tiruthani, Karthik and Card, Madison P and Wolf, Whitney and Shen, Limei and Schaefer, Alison and Fritz, Marshall and Okuda, Kenichi and Harkema, Jack R and Mousa, Jarrod J and J Pickles, Raymond and Lai, Samuel K},
title = {Preferential apical infection and spread of human metapneumovirus highlights the importance of inhaled delivery of neutralizing monoclonal antibody to treat established infections},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
volume = {122},
number = {39},
doi = {10.1073/pnas.2502897122}
}
EUVIMED